Cookson Peirce & CO Inc Pfizer Inc Transaction History

Cookson Peirce & CO Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $199,326 - $233,573	7,891 New	7,891 $220,000
Q4 2022 Jan 31, 2023	BUY	$41.75 - $54.5 $72,478 - $94,612	1,736 Added 0.26%	665,620 $34.1 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $311,046 - $379,709	7,108 Added 1.08%	663,884 $29.1 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $30.6 Million - $36.2 Million	656,776 New	656,776 $34.4 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $36.9 Million - $41.4 Million	-997,963 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $123,787 - $136,001	3,301 Added 0.33%	997,963 $42.4 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $9.44 Million - $10.8 Million	245,282 Added 32.73%	994,662 $41.2 Million
Q3 2018 Oct 15, 2018	BUY	$34.47 - $41.81 $25.8 Million - $31.3 Million	749,380 New	749,380 $0

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.